AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
97 hedge funds and large institutions have $554M invested in Aegerion Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 36 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
28% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 36
36% less capital invested
Capital invested by funds: $865M → $554M (-$311M)
Holders
97
Holding in Top 10
3
Calls
$14.4M
Puts
$7.51M
Top Buyers
| 1 | +$13.3M | |
| 2 | +$11.4M | |
| 3 | +$7.71M | |
| 4 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$7.58M |
| 5 |
Morgan Stanley
New York
|
+$7.21M |
Top Sellers
| 1 | -$60.8M | |
| 2 | -$33.1M | |
| 3 | -$12M | |
| 4 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
-$10.4M |
| 5 |
PA
Perceptive Advisors
New York
|
-$9.97M |